Biohaven Ltd.
BHVN
$9.20
$0.121.32%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 27.96% | -26.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.37% | -37.58% | |||
| Operating Income | -23.37% | 37.58% | |||
| Income Before Tax | 10.29% | 16.17% | |||
| Income Tax Expenses | -22.51% | 58.82% | |||
| Earnings from Continuing Operations | 10.32% | 16.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.32% | 16.08% | |||
| EBIT | -23.37% | 37.58% | |||
| EBITDA | -24.15% | 37.96% | |||
| EPS Basic | 26.98% | 26.11% | |||
| Normalized Basic EPS | 2.08% | 44.67% | |||
| EPS Diluted | 26.98% | 26.11% | |||
| Normalized Diluted EPS | 2.08% | 44.67% | |||
| Average Basic Shares Outstanding | 22.82% | 13.58% | |||
| Average Diluted Shares Outstanding | 22.82% | 13.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||